Clinical Trial · NCT04416165

Comparison of FDG and FAPI in Patients With Various Types of Cancer

Overview

To evaluate the potential usefulness of 68Ga-DOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer, compared with 18F-FDG PET/CT.

Phase

N/A

Contacts

Hua Wu, PhD

wuhua1025@163.com

86 0592-2137166

Haojun Chen, PhD

leochen0821@foxmail.com

86 0592-2137166

ClinicalTrials.gov

NCT04416165